MAPT and early-onset autosomal dominant Alzheimer disease: Hyperphosphorylation of Tau by microtubule affinity regulating kinase 2 (MARK2) was reported as a key event in disrupting the MT binding of Tau and promoting its abnormal aggregation, which is closely associated with Alzheimer’s disease (AD) [35].